Cost-Effectiveness of Hybrid PET/CT for Staging of Non–Small Cell Lung Cancer

Jonas Schreyögg; Julia Weller; Tom Stargardt; Ken Herrmann; Christina Bluemel; Tobias Dechow; Gerhard Glatting; Bernd J. Krause; Felix Mottaghy; Sven N. Reske; Andreas K. Buck

doi:10.2967/jnumed.109.072090

Research ArticleClinical Investigation

Cost-Effectiveness of Hybrid PET/CT for Staging of Non–Small Cell Lung Cancer

Jonas Schreyögg, Julia Weller, Tom Stargardt, Ken Herrmann, Christina Bluemel, Tobias Dechow, Gerhard Glatting, Bernd J. Krause, Felix Mottaghy, Sven N. Reske and Andreas K. Buck

Journal of Nuclear Medicine November 2010, 51 (11) 1668-1675; DOI: https://doi.org/10.2967/jnumed.109.072090

Jonas Schreyögg

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Julia Weller

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tom Stargardt

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ken Herrmann

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christina Bluemel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tobias Dechow

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gerhard Glatting

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bernd J. Krause

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Felix Mottaghy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sven N. Reske

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andreas K. Buck

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 51, Issue 11

November 1, 2010

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Cost-Effectiveness of Hybrid PET/CT for Staging of Non–Small Cell Lung Cancer

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Cost-Effectiveness of Hybrid PET/CT for Staging of Non–Small Cell Lung Cancer

Jonas Schreyögg, Julia Weller, Tom Stargardt, Ken Herrmann, Christina Bluemel, Tobias Dechow, Gerhard Glatting, Bernd J. Krause, Felix Mottaghy, Sven N. Reske, Andreas K. Buck

Journal of Nuclear Medicine Nov 2010, 51 (11) 1668-1675; DOI: 10.2967/jnumed.109.072090

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cost-Effectiveness of Hybrid PET/CT for Staging of Non–Small Cell Lung Cancer

Jonas Schreyögg, Julia Weller, Tom Stargardt, Ken Herrmann, Christina Bluemel, Tobias Dechow, Gerhard Glatting, Bernd J. Krause, Felix Mottaghy, Sven N. Reske, Andreas K. Buck

Journal of Nuclear Medicine Nov 2010, 51 (11) 1668-1675; DOI: 10.2967/jnumed.109.072090

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease
Effect of PET/CT on Management of Patients with Non-Small Cell Lung Cancer: Results of a Prospective Study with 5-Year Survival Data
Large Decreases in Standardized Uptake Values After Definitive Radiation Are Associated with Better Survival of Patients with Locally Advanced Non-Small Cell Lung Cancer
Contribution of Imaging to Cancer Care Costs
18F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
Are Health Economics Making Us Sick?

Google Scholar

Main menu

User menu

Search

Cost-Effectiveness of Hybrid PET/CT for Staging of Non–Small Cell Lung Cancer

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles